Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder

Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder

A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can rapidly and safely reduce symptoms of severe depression. The findings indicate that a single dose of a fast-acting psychedelic compound, administered intravenously, provides sustained relief for up to three months. This research offers early evidence for a mental health treatment that requires much less time in a clinic than ot…